佛慈制药以2000万元现金增资科近泰基公司

Core Viewpoint - The company, Foci Pharmaceutical, is strategically investing in the radioactive isotope drug sector to enhance its core competitiveness by signing an investment agreement with Kejin Taiji New Technology Co., Ltd. [1] Investment Details - On October 10, the company announced a cash investment of 20 million yuan in Kejin Taiji, acquiring a 4.911% stake in the company post-investment [1]. Collaboration and Future Plans - Kejin Taiji is designated as the industrialization entity for medical isotopes by the Institute of Modern Physics of the Chinese Academy of Sciences, indicating a strong collaboration for future projects [1]. - The primary business of Kejin Taiji will involve cooperation with the Institute of Modern Physics and Gansu Isotope Laboratory to engage in the production, sales, operations, and collaborative research and development of medical isotopes [1].